Price $16.16 |
Market Cap
271.4M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
368.6
|
P/B
6.44
|
P/S
16.23
|
Dividend %
-
|
|
P/CF
11.5
|
P/FCF
127.4
|
Op. Cash Flow
2.6K
|
FCF
0.1
|
|
Op. Margin
13.70%
|
Net Margin
8.20%
|
ROE
6.80%
|
ROI
-10.50%
|
|
ROA
6.20%
|
EPS Growth
119.20%
|
Current Ratio
6.6
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Biostem Technologies Inc (BSEM) | $2.87 | - | - | 26M | Strong Buy |
| AMAG Pharmaceuticals, Inc. (AMAG) | $16.71 | - | - | 566.5M | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.27 | - | - | 12.7M | Strong Buy |
| Bausch Health Companies Inc (BHC) | $25.45 | - | - | 8.6B | Strong Buy |
| Acorda Therapeutics Inc (ACOR) | $14.30 | - | - | 790.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
